Level Bio AB (publ) (NGM: LEVBIO)

Market Cap	19.02M
Revenue (ttm)	23.74M
Net Income (ttm)	-12.18M
Shares Out	63.40M
EPS (ttm)	-0.19
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,000
Open	n/a
Previous Close	0.292
Day's Range	n/a
52-Week Range	0.120 - 0.528
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Level Bio AB

Level Bio AB (publ) designs, develops, and distributes diagnostics products in the Nordic region and internationally. The company distributes equipment; consumables and reagents for molecular biology; and research and diagnostic products in Sweden and the Nordics. It also develops, produces, and sells products for genetic fetal diagnostics, as well as genetic miscarriage and infertility diagnostics products. In addition, the company engages in the development of products for congenital heart defect. Its product portfolio includes Rob, an automa...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1998
• Employees: 13
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: LEVBIO

Financial Performance

In 2023, Level Bio AB's revenue was 26.10 million, a decrease of -23.99% compared to the previous year's 34.33 million. Losses were -9.48 million, 326.1% more than in 2022.